FRBA vs CARE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 03, 2026

FRBA

55.2
AI Score
VS
CARE Wins

CARE

55.6
AI Score

Investment Advisor Scores

FRBA

55score
Recommendation
HOLD

CARE

56score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric FRBA CARE Winner
Forward P/E 8.3403 13.6612 FRBA
PEG Ratio 0 0 Tie
Revenue Growth 1.7% 68.3% CARE
Earnings Growth 5.1% 253.9% CARE
Tradestie Score 55.2/100 55.6/100 CARE
Profit Margin 31.7% 44.9% CARE
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

FRBA 1M: +3.0% · 3M: +24.9% CARE 1M: 0.0% · 3M: +35.1%

Current Technical Phase

FRBA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (6.2% over 20 days), RSI 62

RSI (14): 62.3 · Price: $18.53

CARE

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (10.6% over 20 days), RSI 66

RSI (14): 65.5 · Price: $34.58

Fundamentals Snapshot

Metric FRBA CARE
Market Cap
Forward P/E 10.1 13.4
Trailing P/E 11.0 6.0
Revenue (TTM)
Revenue Growth 0.0% 0.7%
Gross Margin 1.0% 1.0%
Operating Margin 0.4% 0.6%
EPS 1.68 5.73
Dividend Yield 0.02% 0.00%

Frequently Asked Questions

Based on our detailed analysis, CARE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.